+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid inhibits tumor development during both AOM-induced colon tumor initiation and progression



Ursodeoxycholic acid inhibits tumor development during both AOM-induced colon tumor initiation and progression



Gastroenterology 120(5 Suppl. 1): A 255




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036012335

Download citation: RISBibTeXText

DOI: 10.1016/s0016-5085(08)81260-7


Related references

Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development. Cancer Epidemiology, Biomarkers and Prevention 11(11): 1316-1321, 2002

CS-706 , a novel COX-2 inhibitor, inhibits tumor-induced hypercalcemia and bone resorption in colon 26 tumor-bearing mice. Proceedings of the American Association for Cancer Research Annual Meeting 44: 920, 2003

Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells. International Journal of Cancer 118(3): 532-539, 2005

Regorafenib Inhibits Tumor Progression of Colon Cancer. 2013

The tumor promoter deoxycholic acid induces apoptosis while the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Gastroenterology 114(4 PART 2): A396, April 15, 1998

Baicalein inhibits tumor progression by inhibiting tumor cell growth and tumor angiogenesis. Oncology Reports 38(5): 3011-3018, 2017

Aged garlic extract inhibits 1,2-dimethylhydrazine-induced colon tumor development by suppressing cell proliferation. Oncology Reports 33(3): 1131-1140, 2015

Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. Journal of Cellular and Molecular Medicine 12(1): 330-342, 2008

Luteolin, a novel natural inhibitor of tumor progression locus 2 serine/threonine kinase, inhibits tumor necrosis factor-alpha-induced cyclooxygenase-2 expression in JB6 mouse epidermis cells. Journal of Pharmacology and Experimental Therapeutics 338(3): 1013-1022, 2011

Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutrition and Cancer 31(2): 111-118, 1998

Tumor-selective proteotoxicity of verteporfin inhibits colon cancer progression independently of YAP1. Science Signaling 8(397): Ra98, 2016

Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression. Clinical Cancer Research 22(10): 2520-2533, 2018

Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains. Carcinogenesis 32(3): 351-358, 2011

Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family. International Journal of Molecular Medicine 38(3): 776-784, 2017

Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. Faseb Journal 7(10): 846-854, 1993